BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 1, 2026
Home » Authors » Omar Ford

Articles by Omar Ford

Look for unusual suspects when detecting glucose monitor errors

July 29, 2011
By Omar Ford
ATLANTA – Back in 2010, the FDA held two meetings to discuss the accuracy and safety of glucose meters. During the meetings the agency pushed for tightening system accuracy criteria specified by current glucose meter standards and considered whether FDA review criteria for these devices should be changed to promote the public health. The FDA solicited feedback from clinical experts about the clinical requirements for blood glucose meter accuracy and precision, and the benefits and risks of using glucose meters to achieve and maintain tight glycemic control. (Medical Device Daily)
Read More

Benefits outweigh risks for DTC genomic testing

July 28, 2011
By Omar Ford
ATLANTA — Is opening the door for direct-to-consumer (DTC) genomic testing actually opening pandora's box? A small panel took on that question Tuesday during the American Association for Clincal Chemistry (AACC; Washington) meeting held here at the Georgia World Congress Center. (Medical Device Daily)
Read More

Combination of molecular tests best at detecting thyroid cancer

July 27, 2011
By Omar Ford
ATLANTA — A picture displaying what appears to be part of a female's abdomen pops up on the screen – with the words next to it "The fastest growing cancer among women isn't what you think." (Medical Device Daily)
Read More

King touts Broca test's ability to detect breast, ovarian cancer

July 26, 2011
By Omar Ford
ATLANTA — To just say that Mary-Claire King PhD, has simply been "instrumental" in the way physicians look at diagnosing breast cancer would be an understatement. King was a pioneer in helping the medical community understand the BRCA1 gene and its role of genetics in the development of breast and ovarian cancer. (Medical Device Daily)
Read More

Parties discuss fallout from Sapien panel vote

July 25, 2011
By Omar Ford

Siemens receives FDA OK for syngo Neuro PBV IR

July 22, 2011
By Omar Ford

Carticept Medical receives FDA approval for NDS

July 21, 2011
By Omar Ford

Cardinal Health launches molecular imaging center

July 20, 2011
By Omar Ford
Cardinal Health (Dublin, Ohio) reported that it has opened The Center for the Advancement of Molecular Imaging – a collaboration that will expedite the development of nuclear imaging agents that treat complex diseases like cancer, heart disease and neurological disorders. (Medical Device Daily)
Read More

Knome's kGAP aids researchers in Parkinson's biomarker discovery

July 19, 2011
By Omar Ford

Ellipse uses 'MAGEC' for treatment of scoliosis

July 18, 2011
By Omar Ford
For years children suffering with early onset scoliosis had to have multiple surgeries to correct spinal deformities. A small med-tech company is aiming to change that standard of care, with an implant that can be adjusted in the patient after it's implanted, remotely. (Medical Device Daily)
Read More
Previous 1 2 … 149 150 151 152 153 154 155 156 157 … 227 228 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 29, 2026.
  • Illustration for mutations in the DNA leading to brain diseases or neurodegenerative disorders

    ENCALS 2026: From genetics to advancing strategies against ALS

    BioWorld Science
    Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 30, 2026
  • Handshake with DNA, molecules

    Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement

    BioWorld Science
    Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
  • Digital brain with dollar sign

    Investors bet on transformative BCI tech for neuro disorders

    BioWorld
    An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing